A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
Manuel Comabella(Universitat Autònoma de Barcelona), Roland Martinꝉ(University of Zurich), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Florian Deisenhammer(Innsbruck Medical University), Lara Nonell(Universitat Autònoma de Barcelona), Eva Julià(Vall d'Hebron Hospital Universitari), Álex Sánchez‐Pla(Universitat de Barcelona), Jordi Río(Universitat Autònoma de Barcelona), Teresa Tórtola(Universitat Autònoma de Barcelona), Cristina López(Universitat Autònoma de Barcelona), M. Camiña-Tato(Universitat Autònoma de Barcelona), Jan D. Lünemann(University Hospital Münster), E. Jiménez Caballero(Universitat Autònoma de Barcelona), Marco Prinz(University of Freiburg)
Cited by 203
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Host microbiota constantly control maturation and function of microglia in the CNS
|Nature Neuroscience|2015|3.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k